Deucravacitinib was safe and effective for treating moderate to severe scalp psoriasis over 16 weeks, even among patients with less extensive overall disease. Deucravacitinib demonstrates significant ...

Guttate psoriasis is a type of psoriasis that shows up on your skin as red, scaly, small, teardrop-shaped spots. Scalp psoriasis is a common skin disorder. It can be a single patch or several ...

Medically reviewed by Doru Paul, MD To confirm a psoriasis diagnosis, your healthcare provider will check your skin and scalp ...

Risankizumab had greater improvements in skin clearance and quality of life at 16 weeks in patients with psoriasis compared with deucravacitinib.

There are a ton of shampoos on the shelves, so what should you buy? Dermatologists share tips to find the healthiest shampoo ...

Topline results were announced from a phase 3 trial evaluating icotrokinra in patients with moderate to severe plaque psoriasis (PsO).

Researchers at the University of Copenhagen have developed a patch for easier and more effective treatment of psoriasis. The ...

Icotrokinra is an investigational oral peptide that blocks interleukin (IL)-23 receptor, which plays a significant role in ...

Scientists from The Second Affiliated Hospital of Zhejiang University have found a potential link between psoriasis, a ...

The study was conducted among patients with plaque psoriasis affecting special areas such as the scalp, genitals and/or hands ...

Psoriasis is a typical chronic inflammatory disease. Typical symptoms are thick plates of silvery white keratin that usually ...